News + Filings Transactions
|
REARDON WILLIAM S
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/06/2021 | Tekla World Healthcare Fund | THW | Exercise (in-the-money or at-the-money) | Subscription rights | 1.5k | $14.26 | $20.8k | | 04/06/2021 |
| 02/25/2021 | Tekla World Healthcare Fund | THW | Purchase | Shares of Beneficial Interest | 1.5k | $17.14 | $25k | | 02/25/2021 |
| 02/25/2021 | Tekla Healthcare Opportunities Fund | THQ | Purchase | Shares of Beneficial Interest | 1.2k | $20.85 | $24.9k | | 02/25/2021 |
| 06/20/2018 | Aceragen, Inc. | IDRA | Grant | | 50k | $1.53 | $76.5k | | 06/20/2018 |
| 06/07/2017 | Aceragen, Inc. | IDRA | Grant | | 50k | $1.63 | $81.5k | | 06/07/2017 |
| 06/13/2016 | Aceragen, Inc. | IDRA | Grant | | 35k | $1.44 | $50.4k | | 06/13/2016 |
| 07/01/2014 | Aceragen, Inc. | IDRA | Grant | Common Stock | 2.4k | $2.83 | $6.7k | | 07/01/2014 |
| 07/01/2014 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Director Stock Option (Right to Buy) | 10k | $4.10 | $41k | | 07/01/2014 |
| 07/01/2014 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Common Stock | 4.9k | $0.00 | $0 | | 07/01/2014 |
| 06/09/2014 | Aceragen, Inc. | IDRA | Grant | Stock Option | 35k | $3.25 | $113.8k | | 06/09/2014 |
| 11/13/2013 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Purchase | Common Stock | 13.3k | $3.75 | $50k | | 11/13/2013 |
| 09/16/2013 | Aceragen, Inc. | IDRA | Purchase | Common Stock | 13.6k | $1.82 | $24.6k | | 09/16/2013 |
| 08/16/2013 | Aceragen, Inc. | IDRA | Grant | Stock Option | 40k | $1.50 | $60k | | 08/16/2013 |
| 03/09/2012 | TEKLA LIFE SCIENCES INVESTORS | HQL | Purchase | Shares of Beneficial Interest | 772 | $13.27 | $10.2k | | 03/09/2012 |
|